US Patent 10617460 Neuromodulation for metabolic conditions or syndromes
Patent 10617460 was granted and assigned to Metavention on April, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 6, 2019
0
Date of Patent
April 14, 2020
0
Patent Applicant
Patent Application Number
16563128
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10617460 Neuromodulation for metabolic conditions or syndromes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
